BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16382664)

  • 1. A comparison of hair quality and cosmetic acceptance following the use of two anti-dandruff shampoos.
    Draelos ZD; Kenneally DC; Hodges LT; Billhimer W; Copas M; Margraf C
    J Investig Dermatol Symp Proc; 2005 Dec; 10(3):201-4. PubMed ID: 16382664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff.
    Schmidt-Rose T; Braren S; Fölster H; Hillemann T; Oltrogge B; Philipp P; Weets G; Fey S
    Int J Cosmet Sci; 2011 Jun; 33(3):276-82. PubMed ID: 21272039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis.
    Piérard-Franchimont C; Goffin V; Decroix J; Piérard GE
    Skin Pharmacol Appl Skin Physiol; 2002; 15(6):434-41. PubMed ID: 12476017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of safety and efficacy of ketoconazole 2% and zinc pyrithione 1% shampoo in patients with moderate to severe dandruff--a postmarketing study.
    Saple DG; Ravichandran G; Desai A
    J Indian Med Assoc; 2000 Dec; 98(12):810-1. PubMed ID: 11394481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis.
    Ratnavel RC; Squire RA; Boorman GC
    J Dermatolog Treat; 2007; 18(2):88-96. PubMed ID: 17520465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff.
    Danby FW; Maddin WS; Margesson LJ; Rosenthal D
    J Am Acad Dermatol; 1993 Dec; 29(6):1008-12. PubMed ID: 8245236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment.
    Lorette G; Ermosilla V
    Eur J Dermatol; 2006; 16(5):558-64. PubMed ID: 17101479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incubatory environment of the scalp impacts pre-emergent hair to affect post-emergent hair cuticle integrity.
    Schwartz JR; Henry JP; Kerr KM; Flagler MJ; Page SH; Redman-Furey N
    J Cosmet Dermatol; 2018 Feb; 17(1):105-111. PubMed ID: 28504468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp.
    Buechner SA
    J Dermatolog Treat; 2014 Jun; 25(3):226-31. PubMed ID: 23557492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro efficacy of antifungal agents alone and in shampoo formulation against dandruff-associated Malassezia spp. and Staphylococcus spp.
    Leong C; Schmid B; Buttafuoco A; Glatz M; Bosshard PP
    Int J Cosmet Sci; 2019 Jun; 41(3):221-227. PubMed ID: 30851208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The myrtus communis L. solution versus ketoconazole shampoo in treatment of dandruff: A double blinded randomized clinical trial.
    Chaijan MR; Handjani F; Zarshenas M; Rahimabadi MS; Tavakkoli A
    J Pak Med Assoc; 2018 May; 68(5):715-720. PubMed ID: 29885168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [1% econazole hair-shampoo in the treatment of pityriasis capitis; a comparative study versus zinc-pyrithione shampoo].
    Rigoni C; Toffolo P; Cantù A; Beretta D; Terenzio C
    G Ital Dermatol Venereol; 1989; 124(11-12):LXVII-LXX. PubMed ID: 2638641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced efficacy and sensory properties of an anti-dandruff shampoo containing zinc pyrithione and climbazole.
    Turner GA; Matheson JR; Li GZ; Fei XQ; Zhu D; Baines FL
    Int J Cosmet Sci; 2013 Feb; 35(1):78-83. PubMed ID: 22970742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis.
    Squire RA; Goode K
    J Dermatolog Treat; 2002 Jun; 13(2):51-60. PubMed ID: 12060502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antifungal action of dandruff shampoos.
    Bulmer AC; Bulmer GS
    Mycopathologia; 1999; 147(2):63-5. PubMed ID: 10967964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dandruff/seborrhoeic dermatitis is characterized by an inflammatory genomic signature and possible immune dysfunction: transcriptional analysis of the condition and treatment effects of zinc pyrithione.
    Mills KJ; Hu P; Henry J; Tamura M; Tiesman JP; Xu J
    Br J Dermatol; 2012 Jun; 166 Suppl 2():33-40. PubMed ID: 22670617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis.
    Seite S; Rougier A; Talarico S
    J Cosmet Dermatol; 2009 Dec; 8(4):249-53. PubMed ID: 19958427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shampoos: ingredients, efficacy and adverse effects.
    Trüeb RM
    J Dtsch Dermatol Ges; 2007 May; 5(5):356-65. PubMed ID: 17451380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial.
    Peter RU; Richarz-Barthauer U
    Br J Dermatol; 1995 Mar; 132(3):441-5. PubMed ID: 7718463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial.
    Berger RS; Fu JL; Smiles KA; Turner CB; Schnell BM; Werchowski KM; Lammers KM
    Br J Dermatol; 2003 Aug; 149(2):354-62. PubMed ID: 12932243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.